Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1964 1
1984 1
1986 2
1987 1
1988 2
1989 2
1990 3
1991 2
1992 2
1994 5
1995 5
1996 4
1997 2
1998 3
1999 9
2000 6
2001 7
2002 4
2003 3
2004 6
2005 9
2006 6
2007 10
2008 3
2009 8
2010 8
2011 11
2012 9
2013 11
2014 9
2015 9
2016 18
2017 13
2018 14
2019 10
2020 4
2021 2
Text availability
Article attribute
Article type
Publication date

Search Results

203 results
Results by year
Filters applied: . Clear all
Page 1
Targeting Bcl-2 for the treatment of multiple myeloma.
Touzeau C, Maciag P, Amiot M, Moreau P. Touzeau C, et al. Among authors: amiot m. Leukemia. 2018 Sep;32(9):1899-1907. doi: 10.1038/s41375-018-0223-9. Epub 2018 Aug 3. Leukemia. 2018. PMID: 30076373 Review.
Efficacy of venetoclax as targeted therapy for relapsed/refractory t(11;14) multiple myeloma.
Kumar S, Kaufman JL, Gasparetto C, Mikhael J, Vij R, Pegourie B, Benboubker L, Facon T, Amiot M, Moreau P, Punnoose EA, Alzate S, Dunbar M, Xu T, Agarwal SK, Enschede SH, Leverson JD, Ross JA, Maciag PC, Verdugo M, Touzeau C. Kumar S, et al. Among authors: amiot m. Blood. 2017 Nov 30;130(22):2401-2409. doi: 10.1182/blood-2017-06-788786. Epub 2017 Oct 10. Blood. 2017. PMID: 29018077 Free article. Clinical Trial.
Fat-soluble micronutrients and metabolic syndrome.
Goncalves A, Amiot MJ. Goncalves A, et al. Among authors: amiot mj. Curr Opin Clin Nutr Metab Care. 2017 Nov;20(6):492-497. doi: 10.1097/MCO.0000000000000412. Curr Opin Clin Nutr Metab Care. 2017. PMID: 28858890 Free PMC article. Review.
Disruption of IRE1α through its kinase domain attenuates multiple myeloma.
Harnoss JM, Le Thomas A, Shemorry A, Marsters SA, Lawrence DA, Lu M, Chen YA, Qing J, Totpal K, Kan D, Segal E, Merchant M, Reichelt M, Ackerly Wallweber H, Wang W, Clark K, Kaufman S, Beresini MH, Laing ST, Sandoval W, Lorenzo M, Wu J, Ly J, De Bruyn T, Heidersbach A, Haley B, Gogineni A, Weimer RM, Lee D, Braun MG, Rudolph J, VanWyngarden MJ, Sherbenou DW, Gomez-Bougie P, Amiot M, Acosta-Alvear D, Walter P, Ashkenazi A. Harnoss JM, et al. Among authors: amiot m. Proc Natl Acad Sci U S A. 2019 Aug 13;116(33):16420-16429. doi: 10.1073/pnas.1906999116. Epub 2019 Aug 1. Proc Natl Acad Sci U S A. 2019. PMID: 31371506 Free PMC article.
Expression Profile of BCL-2, BCL-XL, and MCL-1 Predicts Pharmacological Response to the BCL-2 Selective Antagonist Venetoclax in Multiple Myeloma Models.
Punnoose EA, Leverson JD, Peale F, Boghaert ER, Belmont LD, Tan N, Young A, Mitten M, Ingalla E, Darbonne WC, Oleksijew A, Tapang P, Yue P, Oeh J, Lee L, Maiga S, Fairbrother WJ, Amiot M, Souers AJ, Sampath D. Punnoose EA, et al. Among authors: amiot m. Mol Cancer Ther. 2016 May;15(5):1132-44. doi: 10.1158/1535-7163.MCT-15-0730. Epub 2016 Mar 3. Mol Cancer Ther. 2016. PMID: 26939706 Free article.
203 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page